09.26.25 -- Hybrid. Continuous. Peptide. Manufacturing. Lilly's Put It All Together.

Unlock the keys to successful First-in-Human studies with Quotient. This webinar reveals how expert-designed SAD/MAD trials, flexible CMC strategies, and smart regulatory planning accelerate proof-of-concept while avoiding costly setbacks. Gain insider insights on biomarkers, patient recruitment, and data integration—plus real-world case studies across rare diseases, obesity, CNS, and inflammation. De-risk early development and keep your program moving forward. Click here to learn more.

Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.

Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.

This beginner-friendly webinar reveals essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

Your pharma or biotech company can take these actionable steps to achieve digital facility operations and successfully build your own facility of the future. 

Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.

The presence of nitrosamine drug substance-related impurities (NDSRIs) in medications has become an urgent issue for the pharmaceutical industry. Understand the acceptable intake (AI) limits.

Whether a biotech is emerging or established, a dedicated CDMO program team offers invaluable support through communication, technical and regulatory guidance, and adaptability to change.

Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.

See how the implementation of a Project Management Office transformed a small manufacturing site into a high-performing, strategic asset within a global network.

Turn compliance into a competitive advantage with this five-module QMS system that works to give teams a holistic view of quality and tear down siloes between departments.

Experience an innovative business model, complete with a network of medicinal chemistry capabilities, that does not add additional costs to your project.

Our analytical and testing services are available as standalone offerings or as complementary support to drug substance and product development and manufacturing, tailored to your program needs.